Home Companies Onchilles Pharma COMPANY
Clinical Phase 2
Keywords: oncology cancer Triple-Negative Breast Neoplasms Squamous Cell Carcinoma of Skin Melanoma Head and Neck Neoplasms Squamous Cell Carcinoma Non-Small-Cell Lung Carcinoma N17350 Show all 9 keywords
Location: San Diego, CA · source · Oct 13, 2026
Profile checked Oct 10, 2026
At a glance HQ San Diego, CA source Stage Clinical Phase 2 Latest trial Phase 1/Phase 2: Intratumoral N17350 in Advanced Solid Tumors (May 25, 2026) source Timeline May 25, 2026 Trial start Phase 1/Phase 2: Intratumoral N17350 in Advanced Solid Tumors source ↗ Upcoming milestones 2028-07 (ESTIMATED) · Phase 1/Phase 2 · Intratumoral N17350 in Advanced Solid Tumors · NCT07339176 Estimated primary completion per ClinicalTrials.gov. Dates move.
Clinical trials (lead sponsor) 1 Record Title Phase Status Start Primary completion NCT07339176 Intratumoral N17350 in Advanced Solid Tumors Phase 1/Phase 2 Recruiting May 25, 2026 2028-07 (estimated)
